| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. | CEO, Director | Restricted Stock Units | 75K | $250K | $3.33 | Apr 1, 2024 | Direct |
| Inozyme Pharma, Inc. | CEO, Director | Common Stock | 22.4K | $99.6K | $4.45 | Sep 30, 2024 | Direct |
| Inozyme Pharma, Inc. | CEO, Director | Stock Option (right to buy) | 300K | Mar 13, 2024 | Direct | ||
| CRISPR Therapeutics AG | Director | Stock Option (Right to Buy) | 13K | May 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INZY | Inozyme Pharma, Inc. | Sep 30, 2024 | 1 | $7.61K | 4 | Oct 3, 2024 | CEO, Director |
| CRSP | CRISPR Therapeutics AG | May 30, 2024 | 1 | $0 | 4 | May 31, 2024 | Director |
| INZY | Inozyme Pharma, Inc. | Apr 1, 2024 | 3 | -$52.2K | 4 | Apr 3, 2024 | CEO, Director |
| INZY | Inozyme Pharma, Inc. | Mar 13, 2024 | 1 | $0 | 4 | Mar 15, 2024 | CEO, Director |
| CRSP | CRISPR Therapeutics AG | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| INZY | Inozyme Pharma, Inc. | Apr 1, 2023 | 2 | $0 | 4 | Apr 4, 2023 | CEO, Director |
| INZY | Inozyme Pharma, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 14, 2022 | Director |
| CRSP | CRISPR Therapeutics AG | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| INZY | Inozyme Pharma, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |
| CRSP | CRISPR Therapeutics AG | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |